GSK plc Adjustments For Fair Value Gains Losses
GSK plc (GLAXF) reported Adjustments For Fair Value Gains Losses of GBP 45.00 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-06.
Financial Statements › Income Statement › Other Income
ifrs-full:AdjustmentsForFairValueGainsLosses · last filed 2026-03-06
| Period end | Adjustments For Fair Value Gains Losses 12 month | Adjustments For Fair Value Gains Losses 12 month as first filed |
|---|---|---|
| 2025-12-31 | 45.00M GBP 20-F · filed 2026-03-06 | |
| 2024-12-31 | -39.00M GBP 20-F · filed 2026-03-06 | |
| 2023-12-31 | -107.00M GBP 20-F · filed 2026-03-06 | |
| 2022-12-31 | -283.00M GBP 20-F · filed 2025-03-03 | |
| 2021-12-31 | -31.00M GBP 20-F · filed 2024-03-05 | -17.00M GBP 20-F · filed 2022-03-08 |
| 2020-12-31 | 373.00M GBP 20-F · filed 2023-03-10 | 464.00M GBP 20-F · filed 2021-03-12 |
| 2019-12-31 | 19.00M GBP 20-F · filed 2022-03-08 | |
| 2018-12-31 | -7.00M GBP 20-F · filed 2021-03-12 | |
| 2016-12-31 | -3.00M GBP 20-F · filed 2019-03-15 |